A leading cancer research charity needed project management and drug development expertise to shepherd two preclinical programs into Phase I/II clinical trials. Alacrita was engaged to provide an expert resource.
Our duties included overseeing the formal preclinical development program, submission of IND and execution of a Phase I/II clinical trial for two of the charity’s targeted therapy compounds. We were responsible for the following: